Study to Investigate the Effects of Talampanel on the Heart Rhythm

- Healthy
- Completed

Study Title: A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

Teva Identifier: TAL-TQT-101 | R09-0539

ClinicalTrials.gov Identifier: NCT00964730

Study Status: Completed

Trial Condition(s): Healthy

Interventions: Drug: Talampanel | Drug: Moxifloxacin | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 18 Years to 50 Years

Trial Duration: 10/01/2009 - 02/01/2010

Phase: Phase 1

Study Type

Interventional